Atopic dermatitis Yardstick: a new era of topical and systemic treatments.

Anna De Benedetto

doi:10.1016/j.anai.2026.05.028

Atopic dermatitis Yardstick: a new era of topical and systemic treatments.

2026-06-01

0

PRE

AI

A

Anna De Benedetto

M

Mark Boguniewicz

L

Luz Fonacier

J

Jonathan Silverberg

K

Katrina Abuabara

P

Peck Y. Ong *

DOI：10.1016/j.anai.2026.05.028

Original

Original request for help

Save

Abstract

En 中文

The atopic dermatitis (AD) Yardstick articles aim to provide an up-to-date review of AD therapy for clinicians. The first two AD Yardstick articles were published in 2018 and 2023. Since the last update, multiple medications have been added to armamentarium of AD. These include roflumilast cream, tapinarof cream, lebrikizumab and nemolizumab. In the current AD Yardstick article, we aim to provide evidence-based information on these new treatments, as well as updated information on previously reviewed therapy. A new feature of the AD Yardstick article is the addition of patient vignettes, which provide practical guide and clinical pearls for clinicians.

Atopic dermatitis Yardstick: a new era of topical and systemic treatments.

Abstract

Journal

Organization